Product Details

Please note that packaging may vary depending on the shipping period.

Characteristics of Cabergoline

Cabergoline is a dopamine receptor agonist marketed by Sun Pharma.

It is used to treat conditions such as Parkinson's disease, hyperprolactinemia, and hyperprolactinemic ovulation disorders.

Effects of Cabergoline

This product can effectively alleviate symptoms of Parkinson's disease by improving hand tremors and limb stiffness caused by dopamine deficiency.

・Improves hand tremors, muscle stiffness, and slow movements caused by Parkinson's disease
 ・Suppresses excessive hormone secretion
 ・Treatment of hyperprolactinemia
 ・Treatment of hyperprolactinemic ovulation disorders
 ・Treatment of hyperprolactinemic pituitary adenomas
 ・Suppression of postpartum milk secretion

Dosage Information

Through this website, you can choose between 0.25mg and 0.5mg formulations.

Other Information

Since prolactin secretion after male ejaculation can lead to decreased libido, this product is particularly suitable for users who wish to prolong sexual activity.

Related Product Pages

Premature Ejaculation Prevention Medications

References

In addition to the product information from the country of sale, this description references the following websites:

Cabergoline - Wikipedia

Administration Method / Usage Instructions

Timing of Administration

Take once daily with water or lukewarm water.

Note: Dosage should be adjusted according to symptoms.

Dosage Reference

Parkinson's Disease

Take once daily after breakfast, regardless of dosage.
Start with 0.25mg daily and adjust to 0.5mg daily in the second week.
Monitor disease progression and increase by 0.5mg weekly until reaching the maintenance dose.
Maximum daily dose should not exceed 3mg.

Galactorrhea, Hyperprolactinemic Ovulatory Dysfunction, Hyperprolactinemic Pituitary Adenoma

Take once weekly before bedtime on a fixed day.
Start with a single 0.25mg dose and gradually increase by 0.25mg at intervals of at least 2 weeks.
Standard single dose: 0.25mg～0.75mg.
Maximum single dose: 1.0mg.

Postpartum Lactation Inhibition

Take a single 1.0mg dose after meals following childbirth.

Effects of Food and Alcohol

No relevant reports currently available.

Contraindications

• History of allergy to memantine hydrochloride or ergot preparations
• Diagnosed (via echocardiography) with valvular thickening, restricted valve movement, or related stenosis
• Patients with puerperal hypertension
• Pregnant women/those with pregnancy toxemia, lactating women, or those who may become pregnant

※Please strictly follow medical instructions.

Side Effects

Main Side Effects

Nausea, loss of appetite, stomach discomfort, dry mouth, vomiting, dizziness, drowsiness, constipation, diarrhea, mouth ulcers, abdominal pain, stomachache, excitement, insomnia, depression, orthostatic hypotension, lowered blood pressure, palpitations, edema, rash, etc.

Serious Side Effects

Hallucinations, malignant syndrome, interstitial pneumonia, pleurisy, valvular heart disease, retroperitoneal fibrosis, sudden onset of sleep, liver dysfunction, angina pectoris, etc.

If these symptoms occur, stop taking the medication immediately and seek medical treatment.

Contraindicated Drug Combinations

Contraindicated Drugs

No relevant reports have been documented yet.

Precautions for Contraindicated Drug Combinations

• Antihypertensive Drugs: May potentiate the blood pressure-lowering effect.
• Dopamine Antagonists / Butyrophenone Derivatives: May competitively antagonize dopamine receptors.
• Macrolide Antibiotics: May suppress the metabolism of this product via CYP3A4 inhibition.

Storage Method

• Store in a cool, dry place away from direct sunlight.
• Keep out of reach of children.
• Do not transfer to other containers to avoid accidental ingestion or quality deterioration.
• Store airtight and consume within 2 days after opening a packet.
• Do not consume or use products past their expiration date.

Manufacturer

Sun Pharmaceutical Industries Limited